These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28049204)

  • 1. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
    Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
    Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
    Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
    Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
    Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
    J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.
    Gorgulu Akin B; Erkoc M; Korkmaz ET; Ozdel Ozturk B; Colak S; Ozalp Ates FS; Bavbek S
    World Allergy Organ J; 2022 Jan; 15(1):100619. PubMed ID: 34992710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypersensitivity Reactions to Taxanes: A Multicenter Study for Outcomes and Safety of Rapid Drug Desensitization.
    Bayrak Durmaz MS; Unutmaz DG; Demir M; Goksel O; Dursun AB; Bavbek S
    Allergy Asthma Immunol Res; 2024 Mar; 16(2):142-153. PubMed ID: 38528382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.
    Madrigal-Burgaleta R; Bernal-Rubio L; Berges-Gimeno MP; Carpio-Escalona LV; Gehlhaar P; Alvarez-Cuesta E
    J Allergy Clin Immunol Pract; 2019 Feb; 7(2):618-632. PubMed ID: 30098410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-stratification protocol for carboplatin and oxaliplatin hypersensitivity: repeat skin testing to identify drug allergy.
    Wang AL; Patil SU; Long AA; Banerji A
    Ann Allergy Asthma Immunol; 2015 Nov; 115(5):422-8. PubMed ID: 26298407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of rapid drug desensitization in children.
    Esenboga S; Akarsu A; Ocak M; Gur Cetinkaya P; Sahiner UM; Sekerel BE; Soyer O
    Pediatr Allergy Immunol; 2022 Mar; 33(3):e13759. PubMed ID: 35338724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.
    Demir S; Soyer O; Bilginer Y; Sag E; Sahiner UM; Buyuktiryaki B; Sekerel BE; Ozen S
    Clin Exp Rheumatol; 2020; 38(3):552-557. PubMed ID: 31820716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors.
    Kang Y; Kwon OY; Jung H; Kang M; An J; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
    Ann Allergy Asthma Immunol; 2019 Jul; 123(1):48-56.e1. PubMed ID: 31108181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: Outcomes and risk factors.
    Caiado J; Brás R; Paulino M; Costa L; Castells M
    Ann Allergy Asthma Immunol; 2020 Sep; 125(3):325-333.e1. PubMed ID: 32353405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
    Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
    Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hypersensitivity reactions to Carboplatin and Paclitaxel in an outpatient oncology infusion center: a 5-year review.
    Banerji A; Lax T; Guyer A; Hurwitz S; Camargo CA; Long AA
    J Allergy Clin Immunol Pract; 2014; 2(4):428-33. PubMed ID: 25017531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate hypersensitivity reactions in pediatrics: Evaluation and management.
    Dilley MA; Lee JP; Broyles AD
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27786403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.
    Altwerger G; Gressel GM; English DP; Nelson WK; Carusillo N; Silasi DA; Azodi M; Santin A; Schwartz PE; Ratner ES
    Gynecol Oncol; 2017 Jan; 144(1):77-82. PubMed ID: 27789084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carboplatin hypersensitivity: does introduction of skin test and desensitization reliably predict and avoid the problem? A prospective single-center study.
    Gomez R; Harter P; Lück HJ; Traut A; Kommoss S; Kandel M; du Bois A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1284-7. PubMed ID: 19823066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization to rituximab in a multidisciplinary setting.
    Amorós-Reboredo P; Sánchez-López J; Bastida-Fernández C; do Pazo-Oubiña F; Borràs-Maixenchs N; Giné E; Valero A; Creus-Baró N
    Int J Clin Pharm; 2015 Oct; 37(5):744-8. PubMed ID: 25999014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies.
    Picard M; Galvão VR
    J Allergy Clin Immunol Pract; 2017; 5(3):600-609. PubMed ID: 28110056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab Hypersensitivity: Evaluation, Desensitization, and Potential Mechanisms.
    Wong JT; Long A
    J Allergy Clin Immunol Pract; 2017; 5(6):1564-1571. PubMed ID: 29122155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.